ARTICLE | Clinical News
BioSpecifics data
March 29, 1993 8:00 AM UTC
BioSpecifics Technologies Corp. (BSTC) BioSpecifics Technologies Corp. (BSTC) said that in a double-blind study of its collagenase in 49 patients with Peyronie's Disease, eight of the 22 patients in...